SLF:TSXSun Life Financial Inc. Analysis
Data as of 2026-03-10 - not real-time
CA$86.30
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Sun Life Financial (SLF) is trading at C$86.3, which sits just above the 200‑day SMA of 85.25 but below the 20‑day (89.60) and 50‑day (87.92) averages, indicating a short‑term pull‑back within a longer‑term bullish framework. The RSI of 40.9 suggests neutral momentum, while the MACD histogram is negative (-0.45) and the signal line is labeled bearish, flagging a modest downside pressure in the near term. Volume trends are decreasing, and the price is hovering near the identified support level of 85.43, with resistance at 94.76. Recent news highlighted a declared dividend and a Q4 2025 earnings beat, with underlying net income jumping 13%, reinforcing the company’s earnings momentum. The stock offers a solid 4.17% dividend yield and a payout ratio of 57%, which appears sustainable given strong operating cash flow and a cash pile of C$99.8 bn despite a negative free cash flow figure. Valuation metrics show a trailing PE of 14.0 versus an industry average of 17.4, and a forward PE of 10.0, positioning SLF as a relative value play. The DCF‑derived fair value of C$198.6 and analyst price targets averaging around C$96 imply upside potential of roughly 10‑12%. With a low beta of 0.40 and 30‑day volatility of 26.8%, the stock exhibits modest price swings. Debt‑to‑equity stands at a high 90%, but the balance sheet is cushioned by ample cash reserves. Overall, the blend of defensive dividend income, attractive valuation, and global diversification supports a positive outlook, though short‑term technical weakness warrants caution.
Given the macro‑environment of “Extreme Greed” in market sentiment, the company’s stable earnings, and its defensive sector positioning, we view SLF as an undervalued, blend‑style investment with sustainable dividend prospects and manageable risk, suitable for investors seeking both income and modest capital appreciation.
Given the macro‑environment of “Extreme Greed” in market sentiment, the company’s stable earnings, and its defensive sector positioning, we view SLF as an undervalued, blend‑style investment with sustainable dividend prospects and manageable risk, suitable for investors seeking both income and modest capital appreciation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram and decreasing volume signal near‑term weakness
- Price near technical support at 85.43
- Dividend yield provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to peers (PE 14 vs industry 17)
- Strong earnings growth (13% net income increase) and forward EPS upside
- Attractive dividend yield and sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Robust cash position offsets high debt levels
- Diversified global footprint reduces concentration risk
- Low beta and defensive insurance sector support stability
Key Metrics & Analysis
Financial Health
Revenue Growth4.70%
Profit Margin10.18%
P/E Ratio14.0
ROE13.90%
ROA0.85%
Debt/Equity90.27
P/B Ratio2.1
Op. Cash FlowCA$2.8B
Free Cash FlowCA$-4225999872
Industry P/E17.4
Technical Analysis
TrendBullish
RSI40.9
SupportCA$85.43
ResistanceCA$94.76
MA 20CA$89.60
MA 50CA$87.92
MA 200CA$85.25
MACDBearish
VolumeDecreasing
Fear & Greed Index75.93
Valuation
Fair ValueCA$198.60
Target PriceCA$95.79
Upside/Downside10.99%
GradeUndervalued
TypeBlend
Dividend Yield4.17%
Risk Assessment
Beta0.41
Volatility26.81%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.